Multiple Sclerosis: Immunopathology and Treatment Update

The treatment of multiple sclerosis (MS) has changed over the last 20 years. All immunotherapeutic drugs target relapsing remitting MS (RRMS) and it still remains a medical challenge in MS to develop a treatment for progressive forms. The most common injectable disease-modifying therapies in RRMS in...

Descripción completa

Detalles Bibliográficos
Autores principales: Dargahi, Narges, Katsara, Maria, Tselios, Theodore, Androutsou, Maria-Eleni, de Courten, Maximilian, Matsoukas, John, Apostolopoulos, Vasso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532591/
https://www.ncbi.nlm.nih.gov/pubmed/28686222
http://dx.doi.org/10.3390/brainsci7070078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532591/
https://www.ncbi.nlm.nih.gov/pubmed/28686222
http://dx.doi.org/10.3390/brainsci7070078

Ejemplares similares